WallStSmart

Coca-Cola European Partners PLC (CCEP)vsSRx Health Solutions Inc. (SRXH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 166966% more annual revenue ($21.35B vs $12.78M). CCEP leads profitability with a 9.3% profit margin vs 0.0%. SRXH trades at a lower P/E of 0.0x. CCEP earns a higher WallStSmart Score of 51/100 (C-).

CCEP

Buy

51

out of 100

Grade: C-

Growth: 5.3Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

SRXH

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 5.3
Piotroski: 2/9Altman Z: -5.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPSignificantly Overvalued (-88.1%)

Margin of Safety

-88.1%

Fair Value

$51.90

Current Price

$113.22

$61.32 premium

UndervaluedFair: $51.90Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP1 strengths · Avg: 10.0/10
Return on EquityProfitability
42.7%10/10

Every $100 of equity generates 43 in profit

SRXH2 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

PEG RatioValuation
2.692/10

Expensive relative to growth rate

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$24.02M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity.

Bull Case : SRXH

The strongest argument for SRXH centers on P/E Ratio, Price/Book.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

CCEP is growing revenue faster at 4.4% — sustainability is the question.

CCEP generates stronger free cash flow (604M), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCEP scores higher overall (51/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?